You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clemastine

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Williams Syndrome Trial in Ramat-Gan, Tel Aviv (Open Label Clemastine with a blinded randomize withdrawal)

Recruiting
  • Williams Syndrome
  • Open Label Clemastine with a blinded randomize withdrawal
  • Ramat-Gan, Israel
  • +1 more
Oct 11, 2023

Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

Not yet recruiting
  • Demyelinating Diseases
  • +4 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023

Optic Neuritis Trial in San Francisco (Clemastine, Placebo)

Recruiting
  • Optic Neuritis
  • Clemastine
  • Placebo
  • San Francisco, California
    University of California San Francisco
Jan 5, 2023

Switching H1-antagonist Clemastine to Cetirizine in

Active, not recruiting
  • Solid Tumor
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Sep 8, 2023

Multiple Sclerosis, Internuclear Ophthalmoplegia Trial in Amsterdam (Clemastine Fumarate, Placebo)

Recruiting
  • Multiple Sclerosis
  • Internuclear Ophthalmoplegia
  • Clemastine Fumarate
  • Placebo
  • Amsterdam, Netherlands
    Amsterdam UMC, location VUmc
Sep 21, 2022

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

Recruiting
  • Multiple Sclerosis
  • Metformin and clemastine in combination
  • Placebo
  • Cambridge, United Kingdom
    Addenbrooke's Hospital
Jun 14, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in San Francisco (Clemastine, Placebo)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • Clemastine
  • Placebo
  • San Francisco, California
    UCSF Multiple Sclerosis Center
Sep 22, 2021

Eczema Trial in Osasco (Group 1, Group 2)

Completed
  • Eczema
  • Group 1
  • Group 2
  • Osasco, São Paulo, Brazil
    Medcin instituto da Pele
Jul 1, 2020

Efficacy and Safety Trial in Beijing (Clemastine, Saline Solution)

Completed
  • Efficacy and Safety
  • Clemastine
  • Saline Solution
  • Beijing, Beijing, China
    Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC
Jan 10, 2020

Cancer Trial in Rotterdam (Dexamethasone, H1 Antihistaminics)

Not yet recruiting
  • Cancer
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Nov 1, 2023

Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)

Recruiting
  • Graves Orbitopathy
  • rabbit anti-thymocyte globulin
  • Katowice, Silesia, Poland
    Department of Internal Medicine and Oncological Chemotherapy, Me
Jan 14, 2022

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in San Francisco (Bazedoxifene Acetate)

Recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Bazedoxifene Acetate
  • San Francisco, California
    Weill Institute for Neurosciences, University of California, San
Mar 21, 2022

Autism Spectrum Disorder Trial in Saint Petersburg (umbilical cord blood mononuclear stem cells)

Completed
  • Autism Spectrum Disorder
  • umbilical cord blood mononuclear stem cells
  • Saint Petersburg, Санкт-Петербург, Russian Federation
    St.-Petersburg Bekhterev Reserach Psychoneurological Institute
Aug 2, 2021

Allergy Trial (Clemastine Fumarate Tablets, 2.68 mg (Cord Laboratories), Tavist Tablets, 2.68 mg (Sandoz Pharmaceutical Corp.))

Completed
  • Allergy
  • Clemastine Fumarate Tablets, 2.68 mg (Cord Laboratories)
  • Tavist Tablets, 2.68 mg (Sandoz Pharmaceutical Corp.)
  • (no location specified)
Mar 27, 2017

Healthy Subjects Trial in San Francisco (Clemastine fumarate)

Completed
  • Healthy Subjects
  • Clemastine fumarate
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Nov 2, 2016

Post Operative Pain Control Trial (Dulox capsule (60mg), combined Dulox capsule (60 mg) orally and Dex 0.1mg/kg diluted in 100

Completed
  • Post Operative Pain Control
  • Dulox capsule (60mg)
  • +2 more
  • (no location specified)
Aug 11, 2017

Rhinitis, Allergic, Seasonal Trial in Chicago (Azelastine nasal spray)

Completed
  • Rhinitis, Allergic, Seasonal
  • Azelastine nasal spray
  • Chicago, Illinois
    University of Chicago
Sep 4, 2013

Chronic Urticaria Trial in Germany (Omalizumab 75-375 mg, Placebo to omalizumab, Loratadine)

Completed
Has Results
  • Chronic Urticaria
  • Omalizumab 75-375 mg
  • +3 more
  • Berlin, Germany
  • +10 more
Sep 14, 2011

Allergy, Dermatitis Trial (Dexamethasone + clemastine, Dexamethasone)

Unknown status
  • Allergy
  • Dermatitis
  • (no location specified)
Jan 27, 2011

Angioedema Trial in Munich (Icatibant (subcutaneous) and plazebo (intravenous), Cortisone + Clemastin (intravenous) and plazebo

Completed
  • Angioedema
  • Icatibant (subcutaneous) and plazebo (intravenous)
  • Cortisone + Clemastin (intravenous) and plazebo (subcutaneous)
  • Munich, Bavaria, Germany
    Klinikum rechts der Isar Hals-Nasen-Ohrenklinik der TUM
Dec 22, 2011

Dermatitis Trial in Valinhos (dexamethasone 0.5 mg and 1.0 mg clemastine cream, Dexamethasone 0,5 mg cream)

Withdrawn
  • Dermatitis
  • dexamethasone 0.5 mg and 1.0 mg clemastine cream
  • Dexamethasone 0,5 mg cream
  • Valinhos, São Paulo, Brazil
  • +1 more
Oct 25, 2010